With AI shifting the role of software engineers, Google's senior director of product says more developers will be involved in ...

Data science is sometimes described as a diverse field. It differs from data analytics in that it calls for domain ...

Cybin® is a late-stage breakthrough neuropsychiatry company committed to revolutionizing mental healthcare by developing new and innovative next-generation treatment options to address the large unmet ...

Discover the top 7 most in-demand college majors in the U.S. for 2025, including Computer Science, Nursing, and Business ...

Up to 235% increase in real-world adherence compared to published norms (20–40%), across ~850 chronic obstructive pulmonary disease (COPD) and asthma patients. >60% patients achieved an average ...

Athos Therapeutics launches a new AI platform, Athos Omics AI, to provide no-code, micro-analytics for drug, food, and ...

NPM-139 has potential to provide Wegovy ®-level efficacy with once or twice-yearly administration First-in-human Phase 1 study is expected to initiate in the first half of 2026, pending regulatory ...

In recent years, significant therapeutic advances across multiple disease areas—including immuno-oncology, metabolic diseases such as type 2 diabetes and ...

The healthcare technology landscape continues to evolve at an unprecedented pace, driven by the convergence of digital transformation, cloud-native architectures, and intelligent automation. As ...

Joseph Alderman et al argue that predictive models in healthcare lack adequate oversight and regulation. They highlight the ...

Data obtained from ongoing third-party funded, investigator-sponsored trials have been submitted in effort to address the December 2024 complete response letter Company seeks alignment on reasonable ...